First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study

Kathy Monteith, Lisa McSweeney, Colm R. Breathnach, Lucy Sherrin, Patrick Dicker, Elizabeth C. Tully, John O'Loughlin, Sharon Campbell, Greg Byrne, Fergal D. Malone, Afif El-Khuffash, Etaoin Kent, Ann Doherty

Research output: Contribution to conferencePosterpeer-review

Abstract

To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).
Original languageEnglish
PagesS207-S207
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • non-invasive cardiac output monitoring
  • NICOM
  • non-invasive maternal hemodynamic assessment
  • bioreactance
  • first trimester biomarkers
  • gestational hypertension
  • GH
  • pre-eclampsia
  • PE
  • normotensive fetal growth restriction
  • FGR

Fingerprint

Dive into the research topics of 'First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study'. Together they form a unique fingerprint.

Cite this